Latest filing published 04 Mar 2013 for MAP Pharmaceuticals, Inc., €4.3M.
No signal scores available.
This profile gathers the share dealings of Thomas A. Armer in MAP Pharmaceuticals, Inc. Between 26 May 2009 and 1 March 2013, the trades on record add up to 22 filings.
On the market, this insider has only sold: 11 sales, €3.4M in total. Besides market trades, the filings include 3 share grants and 7 option exercises. 2013 to date brings no purchases and 1 sale.
The record was last updated on 4 March 2013 with a transaction (€4.3M) in MAP Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations